Y0001229

Fosinopril Unreinheit B

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): (2RS,4RS)-4-Cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)-propoxy](4-phenylbutyl)-phosphoryl]-acetyl]-pyrrolidin-2-carbonsäure
• Empirische Formel (Hill-System): C₃₀H₄₆NO₇P
• Molekulargewicht: 563.66
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: fosinopril
• Hersteller/Markenname: EDQM
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• Lagertemp.: 2-8°C

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Fosinopril impurity B EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08,GHS07
• Signalwort: Warning
• H-Sätze: H319,H361d
• P-Sätze: P202 - P264 - P280 - P305 + P351 + P338 - P308 + P313 - P337 + P313
• Gefahreneinstufungen: Eye Irrit. 2 - Repr. 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable